Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymic Epithelial Tumor Hypofractionated Adjuvant Radiotherapy (THOR): A Multi-center Single-Arm Prospective Clinical Trial

NCT07693855 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07693855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymic Epithelial Tumor Hypofractionated Adjuvant Radiotherapy (THOR): A Multi-center Single-Arm Prospective Clinical Trial
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
April 30, 2035
Enrollment
69 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

thymic carcinoma, thymic epithelial tumor, thymoma, thymus neoplasms